Hematologic toxicity in RTOG 0418: A phase 2 study of postoperative IMRT for gynecologic cancer

International Journal of Radiation Oncology Biology Physics

Volumn 86, Issue 1, 2013, Pages 83-90

  Klopp, Ann H ^a   Moughan, Jennifer ^b   Portelance, Lorraine ^c   Miller, Brigitte E ^d   Salehpour, Mohammad R ^a   Hildebrandt, Evangeline ^a   Nuanjing, Jenny ^a   D'Souza, David ^e   Souhami, Luis ^c   Small, William ^f   Gaur, Rakesh ^g   Jhingran, Anuja ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b RTOG Statistical Center   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d WAKE FOREST UNIVERSITY   (United States)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^g Division of Gynecologic Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; COMPUTERIZED TOMOGRAPHY; DISEASES; RADIOTHERAPY;

BONE MARROW; CANCER PATIENTS; CERVICAL CANCERS; CIS-PLATIN; CISPLATIN; ENDOMETRIAL CANCER; HEMATOLOGIC TOXICITY; HIGH RATE; INTENSITY-MODULATED RADIATION THERAPY; RADIATION THERAPY ONCOLOGY GROUPS;

TOXICITY;

CISPLATIN;

ACCURACY; ADVERSE OUTCOME; ARTICLE; BLOOD TOXICITY; BONE MARROW; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; UTERINE CERVIX CANCER;

EID: 84876030531     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2013.01.017     Document Type: Article

References (14)

1. X. Cao, X. Wu, and D. Frassica Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells Proc Natl Acad Sci U S A 108 2011 1609 1614
2. K. Greven, K. Winter, and K. Underhill Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer Int J Radiat Oncol Biol Phys 59 2004 168 173 (Pubitemid 38501521)
3. L.K. Mell, H. Tiryaki, and K.H. Ahn Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer Int J Radiat Oncol Biol Phys 71 2008 1504 1510 (Pubitemid 351978176)
4. B.S. Rose, B. Aydogan, and Y. Liang Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy Int J Radiat Oncol Biol Phys 79 2011 800 807
5. L.K. Mell, D.A. Schomas, and J.K. Salama Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 70 2008 1431 1437 (Pubitemid 351417769)
6. L.K. Mell, J.D. Kochanski, and J.C. Roeske Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy Int J Radiat Oncol Biol Phys 66 2006 1356 1365
7. K. Albuquerque, D. Giangreco, and C. Morrison Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT Int J Radiat Oncol Biol Phys 79 2011 1043 1047
8. K. Lim, W. Small Jr., and L. Portelance Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer Int J Radiat Oncol Biol Phys 79 2011 348 355
9. W.A. Peters 3rd, P.Y. Liu, and R.J. Barrett 2nd Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613 (Pubitemid 30220538)
10. R. Pearcey, M. Brundage, and P. Drouin Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix J Clin Oncol 20 2002 966 972 (Pubitemid 34141839)
11. K. Greven, K. Winter, and K. Underhill Final analysis of RTOG 9708: Adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer Gynecol Oncol 103 2006 155 159 (Pubitemid 44374683)
12. A. Duenas-Gonzalez, J.J. Zarba, and F. Patel Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix J Clin Oncol 29 2011 1678 1685
13. A.H. Klopp, and P.J. Eifel Chemoradiotherapy for cervical cancer in 2010 Curr Oncol Rep 13 2011 77 85
14. B.M. Beadle, A. Jhingran, and M. Salehpour Cervix regression and motion during the course of external beam chemoradiation for cervical cancer Int J Radiat Oncol Biol Phys 73 2009 235 241